Three lines of investigation indicated that hydrogen peroxide (H202) from xanthine oxidase (XO) contributes to cardiac dysfunction during reperfusion after ischemia. First, addition of dimethylthiourea (DMTU), a highly permeant 02 metabolite scavenger (but not urea) simultaneously with reperfusion improved recovery of ventricular function as assessed by ventricular developed pressure (DP), contractility (+dP/dt), and relaxation rate (-dP/dt) in isolated Krebs-Henseleit-perfused rat hearts subjected to global normothermic ischemia. Second, hearts from rats fed tungsten or treated with allopurinol had negligible XO activities (< 0.5 mU/g wet myocardium compared with > 6.0 mU/g in control hearts) and increased ventricular function after ischemia and reperfusion. Third, myocardial H202-dependent inactivation of catalase occurred after reperfusion following ischemia, but not after ischemia without reperfusion or perfusion without ischemia. In contrast, myocardial catalase did not decrease during reperfusion of ischemic hearts treated with DMTU, tungsten, or allopurinol.
Introduction
Although ischemic heart disease remains a leading cause of death, recent advances in techniques that reestablish blood flow have raised hope regarding improved salvage of ischemic myocardium (1, 2) . However, along with these advances has come concern regarding the existence and causes of injury produced by reperfusion. A role for xanthine oxidase (XO)'-derived 02 metabolites (3) (4) (5) has been suggested, but a number of crucial aspects remain unknown. In particular, the nature, timing, source, and significance of 02 metabolites have not been fully determined, in part because of the complexity of studies in intact animal models and human subjects. We addressed these issues by hypothesizing that generation of hydrogen peroxide (H202) by XO during reperfusion contributes to cardiac reperfusion injury. We tested this premise in simplified ("blood-free") isolated hearts using dimethylthiourea (DMTU), a highly permeant 02 metabolite scavenger, infused only during reperfusion (6) . We also assessed the effect of inhibiting XO (by HPLC analysis) with tungsten (7) (8) (9) or allopurinol (10) on ventricular function after ischemia and reperfusion. In addition, we measured H202-dependent aminotriazole inactivation of myocardial catalase activity as an indicator of myocardial H202 production (1 1, 12 (13) . A gas mixture (92.5% 02/7.5% C02) was used (Shirley Membrane), which achieved a Po2 = 450, PCo2 = 40, and pH = 7.4. A water-filled latex balloon was placed through the left atrium into the left ventricle, secured with an atrial 6-0 silk purse string suture and adjusted to a left ventricular end diastolic pressure of 6 mmHg. Pacing wires (rate 300 beats per minute; turned off during ischemia) were attached to the pulmonary outflow tract. After equilibration for 15 min, ventricular developed pressure (DP) and the positive (+dP/dt) and negative (-dP/dt) first derivatives were recorded using direct pressure and differentiator amplifiers. Subsequently, hearts were subjected to global normothermic (37°C waterbath) ischemia (aortic root stopcock) and reperfusion. 
Results
Effect ofDMTU or urea treatment on ventricularfunction after ischemia and reperfusion. Measurements of ventricular function, including ventricular DP, contractility (+dP/dt), and relaxation rate (-dP/dt), were the same (P > 0.05) in all hearts studied before ischemia or (P > 0.05) after perfusion for 60 min without ischemia (Fig. 1) . However, hearts subjected to ischemia for 20 min and then reperfused for 40 min had decreased (P < 0.05) ventricular function compared with hearts studied before ischemia or subjected to perfusion for 60 min without ischemia. In contrast, hearts subjected to ischemia and then treated with DMTU simultaneously with reperfusion had increased (P < 0.05) ventricular function compared with hearts subjected to ischemia and then reperfused with urea or no additions.
Effect of tungsten or allopurinol treatment on myocardial XO activity and ventricularfunction after ischemia and reperfusion. After ischemia for 20 min, hearts from rats treated with tungsten or allopurinol had decreased (P < 0.05) XO activities compared with untreated hearts (Fig. 2) . In addition, after ischemia for 20 min and reperfusion for 40 min, hearts from rats treated with tungsten or allopurinol had increased (P < 0.05) ventricular function compared with untreated hearts (Fig. 3) . , and (c) relaxation rate (-dP/dt) were the same (P > 0.05) in all hearts (untreated, DMTU, or urea treated) studied before ischemia. In addition, perfusion for 60 min without ischemia did not change (P < 0.05) DP, +dP/dt, or -dP/dt from preischemic values. However, after ischemia for 20 min and reperfusion for 40 min, untreated hearts had decreased ventricular function compared with hearts studied before ischemia or after perfusion for 60 min without ischemia. In contrast, after ischemia for 20 min and reperfusion for 40 min, hearts infused with 19.2 mM DMTU (0.2 cm3/min at aortic root) simultaneously with reperfusion had increased (P < 0.05) DP, +dP/dt, and -dP/dt values compared with untreated hearts or hearts infused with equimolar urea. Each bar is the mean± 1 SE of the number of determinations shown within the parentheses.
Effect of DMTU, urea, tungsten, or allopurinol treatment on myocardial catalase activities in aminotriazole-treated rats subjected to ischemia and reperfusion. Catalase activities were the same in hearts perfused for 60 min without ischemia or subjected to ischemia for 20 min without reperfusion (Fig. 4) . However, when subjected to ischemia for 20 min and then 1298 Brown, Terada, Grosso, Whitmann, Velasco, Patt, Harken, and Repine reperfusion for 40 min, catalase activities were decreased (P < 0.05) in untreated or urea-treated hearts compared with DMTU-, tungsten-, or allopurinol-treated hearts.
Discussion
Our results provide evidence that H202 is generated during reperfusion of ischemic, isolated, perfused rat hearts. Specifically, we found that catalase activities decreased in hearts from aminotriazole-treated rats during reperfusion after ischemia, but not in hearts subjected to ischemia without reperfusion or perfusion without ischemia. Since aminotriazole is highly specific for the first intermediate in the reaction of catalase with H202 (compound I), assessing H202-mediated inactivation of catalase reflects H202 generation in biological systems (1 1-13) . Moreover, addition of DMTU only during reperfusion not only prevented decreases in cardiac function, but also prevented H202-dependent decreases in myocardial catalase activity after reperfusion of ischemic hearts. Although DMTU can react with H202, hydroxyl radical ( -OH), or hypochlorous acid (HOCI) in vitro (6, 17) , the additional finding that DMTU decreased H202-mediated inactivation of catalase in hearts from aminotriazole-treated rats further suggests that H202 participates in cardiac reperfusion injury. Moreover, * OH is usually generated from H202 in vivo (3); a contribution from HOCI seems unlikely since production of HOCI from H202 +dP dt requires neutrophil myeloperoxidase (18) and essentially no neutrophils are present in the isolated Krebs-Henseleit perfused heart. Thus, our findings suggest that H202 is made during reperfusion and that H202 contributes either directly or indirectly to the development ofcardiac dysfunction after ischemia.
Our study also indicates that XO generates H202 during reperfusion of ischemic rat hearts. Parallel decreases in myocardial XO activity, ventricular dysfunction, and H202 generation occurred in tungsten-or allopurinol-treated rats subjected to ischemia and then reperfusion. Tungsten is a relatively specific inhibitor that inactivates xanthine, aldehyde, and sulfite oxidases by interfering with their molybdenum-dependent active site (7) (8) (9) . By comparison, allopurinol and its metabolite oxipurinol are potent, specific competitive inhibitors of XO (10), but not sulfite or aldehyde oxidases. Accordingly, measurable inhibition of XO by either tungsten or allopurinol treatment, in conjunction with improved function and lessened myocardial H202 generation, focuses on XO as the predominant source of H202 production during reperfusion after ischemia. Furthermore, because isolated hearts contain virtually no circulating blood elements, participation of 02 metabolites from neutrophils, platelets, or other blood sources is unlikely.
Finally, DMTU, tungsten, or allopurinol treatment prevented H202-dependent decreases in catalase after reperfusion, but did not completely eradicate ventricular dysfunction after reperfusion. Thus, cardiac dysfunction following reperfusion after ischemia may also depend on mechanisms that are independent of processes involving H202 made by XO.
